Login Contact Us
Apr 2018, Vol 6, Issue 2
Advanced Search
How do you find the scientific quality of the published articles on our web site?
Case Report
A Case Report of Fatal Outcome of Cerebral Venous Sinus Thrombosis With Cerebral Hemorrhage During Early Pregnancy Secondary to Antithrombin III Deficiency
Nurezwana Elias, Kavitha MurajRajamany, Noor Azmi Mat Adenan
Department of Obstetrics and Gynaecology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia

IJWHR 2018; 6: 220-222
DOI: 10.15296/ijwhr.2018.37
Viewed : 3463 times
Downloaded : 3318 times.

Keywords : Sinus thrombosis, Intracranial, Antithrombin III deficiency, Pregnancy, Anticoagulants
Full Text(PDF) | Related Articles
Objectives: Cerebral venous sinus thrombosis (CVST) with cerebral hemorrhage is relatively rare but may result in a catastrophic outcome. Antithrombin III deficiency is an inherited disease that contributes to an increase in the occurrence of thromboembolic events during pregnancy.

Case Presentation: A nulliparous, 34-year-old Chinese woman at 9 weeks of pregnancy with underlying antithrombin III deficiency was under treatment with low dose molecular weight heparin. She presented with a frontal headache and projectile vomiting. A plain computed tomography (CT) scan and magnetic resonance angiography and venography (MRAV) of the brain showed features suggestive of CVST involving superior sagittal sinus with venous infarct and right frontal and left parietal intraparenchymal hemorrhage. During admission, she developed episodes of fainting and loss of consciousness. A repeated brain CT scan showed worsening intraparenchymal hemorrhages with midline shift, subfalcine herniation and cerebral edema. An emergency bilateral craniectomy was performed to relieve the intracranial pressure. Despite the surgery and supportive measures, the patient succumbed to death.

Conclusion: Due to the highly hypercoagulable state of pregnancy with concomitant antithrombin III deficiency, preconception counselling including optimization of anticoagulant dosage is crucial. In addition, the administration of antithrombin III concentrate should be considered during pregnancy for women with antithrombin deficiency.

Cite By, Google Scholar

Google Scholar

Articles by Elias N
Articles by Murajrajamany K
Articles by Azmi Mat Adenan N


Articles by Nurezwana Elias

Submit Paper
Online Submission System
IJWHR ENDNOTE ® Style Tutorials Publication Charge Women's Reproductive Health Research Center About Journal
Publication Information
Published Article Statistics